iRhythm Holdings (IRTC) Cash from Financing Activities (2015 - 2026)
iRhythm Holdings (IRTC) posted quarterly Cash from Financing Activities of $149000.0 for Q1 2026, down 91.38% year-over-year from $1.7 million in Q1 2025, and down 94.96% quarter-over-quarter from $3.0 million in Q4 2025.
iRhythm Holdings (IRTC) Cash from Financing Activities (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has reported Cash from Financing Activities for 12 consecutive years, with $149000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 91.38% year-over-year to $149000.0; the TTM figure through Mar 2026 stood at $11.0 million (up 30.2% YoY), while the FY2025 annual figure was $12.6 million, down 97.53% from the prior year.
- Cash from Financing Activities retreated to $149000.0 in Q1 2026 per IRTC's latest filing, from $3.0 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $504.6 million in Q1 2024 and bottomed at -$35000.0 in Q3 2024.
- Historically, Cash from Financing Activities has averaged $32.9 million across 5 years, with a median of $3.0 million in 2024.
- On a YoY basis, Cash from Financing Activities climbed as much as 55661.44% in 2024 and fell as far as 153.03% in 2024.
- iRhythm Holdings' Cash from Financing Activities stood at $3.1 million in 2022, then advanced by 10.17% to $3.5 million in 2023, then dropped by 13.87% to $3.0 million in 2024, then declined by 0.94% to $3.0 million in 2025, then plunged by 94.96% to $149000.0 in 2026.
- Business Quant data shows IRTC's Cash from Financing Activities at $149000.0 in Q1 2026, $3.0 million in Q4 2025, and $825000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | iRhythm Holdings | 4.23 Bn | 3.64 Bn | 163.21 Mn | 4.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.08 Mn |
| Jun 30, 2026 | 4.08 Mn |
| Mar 31, 2026 | 149,000.00 |
| Mar 31, 2026 | 149,000.00 |
| Dec 31, 2025 | 2.96 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Sep 30, 2025 | 825,000.00 |
| Sep 30, 2025 | 825,000.00 |
| Jun 30, 2025 | 7.09 Mn |
| Jun 30, 2025 | 7.09 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 2.99 Mn |
| Dec 31, 2024 | 2.99 Mn |
| Sep 30, 2024 | -35,000.00 |
| Sep 30, 2024 | -35,000.00 |
| Jun 30, 2024 | 3.79 Mn |
| Jun 30, 2024 | 3.79 Mn |
| Mar 31, 2024 | 504.64 Mn |
| Mar 31, 2024 | 504.64 Mn |